These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35999567)

  • 21. LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity.
    Kim S; Jin JS; Choi YJ; Kim J
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33238548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel
    Khan FM; Gondil VS; Li C; Jiang M; Li J; Yu J; Wei H; Yang H
    Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria.
    Lai MJ; Lin NT; Hu A; Soo PC; Chen LK; Chen LH; Chang KC
    Appl Microbiol Biotechnol; 2011 Apr; 90(2):529-39. PubMed ID: 21264466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LysJEP8: A promising novel endolysin for combating multidrug-resistant Gram-negative bacteria.
    Carratalá JV; Ferrer-Miralles N; Garcia-Fruitós E; Arís A
    Microb Biotechnol; 2024 Jun; 17(6):e14483. PubMed ID: 38864495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Truncated CHAP Modular Endolysin, CHAP
    Choi YJ; Kim S; Dahal RH; Kim J
    J Microbiol Biotechnol; 2024 Aug; 34(8):1718-1726. PubMed ID: 39081246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Three Different Endolysins Effective against Gram-Negative Bacteria.
    Jeong TH; Hong HW; Kim MS; Song M; Myung H
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unveiling the mechanism of bactericidal activity of a cecropin A-fused endolysin LNT113.
    Cho J; Hong HW; Park K; Myung H; Yoon H
    Int J Biol Macromol; 2024 Mar; 260(Pt 1):129493. PubMed ID: 38224804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of endolysin-containing liposomes and evaluation of their antimicrobial activities against gram-negative bacteria.
    Bai J; Yang E; Chang PS; Ryu S
    Enzyme Microb Technol; 2019 Sep; 128():40-48. PubMed ID: 31186109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Novel Chimeric Endolysin Conjugated with Chitosan-Zn-Metal-Organic Framework Nanocomposites with Antibacterial Activity.
    Malekian M; Fahimi H; Niri NM; Khaleghi S
    Appl Biochem Biotechnol; 2024 Feb; 196(2):616-631. PubMed ID: 37166650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of key amino acids of Salmonella phage endolysin LysST-3 and detection of its mutants' activity.
    Liu B; Chang Z; Li Z; Liu R; Liu X
    Arch Microbiol; 2024 Mar; 206(4):151. PubMed ID: 38467842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Endolysin LysECP26 Derived from rV5-like Phage vB_EcoM-ECP26 for Inactivation of
    Park DW; Park JH
    J Microbiol Biotechnol; 2020 Oct; 30(10):1552-1558. PubMed ID: 32699198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. External lysis of Escherichia coli by a bacteriophage endolysin modified with hydrophobic amino acids.
    Yan G; Yang R; Fan K; Dong H; Gao C; Wang S; Yu L; Cheng Z; Lei L
    AMB Express; 2019 Jul; 9(1):106. PubMed ID: 31309363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of endolysin across outer membrane of Gram-negative bacteria using translocation domain of botulinum neurotoxin.
    Park W; Park M; Chun J; Hwang J; Kim S; Choi N; Kim SM; Kim S; Jung S; Ko KS; Kweon DH
    Int J Antimicrob Agents; 2024 Aug; 64(2):107216. PubMed ID: 38795926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness of endolysin ENDO-1252 from Salmonella bacteriophage-1252 against nontyphoidal Salmonella enterica.
    Tung CW; Julianingsih D; Canagarajah C; Sellers G; Scriba A; Alvarado-Martínez Z; Tabashsum Z; Biswas D
    FEMS Microbiol Lett; 2024 Jan; 371():. PubMed ID: 38970360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endolysins of bacteriophage vB_Sal-S-S10 can naturally lyse Salmonella enteritidis.
    Wang X; Han L; Rong J; Ren H; Liu W; Zhang C
    BMC Vet Res; 2022 Nov; 18(1):410. PubMed ID: 36411417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of five novel endolysins from Gram-negative infecting bacteriophages.
    Walmagh M; Boczkowska B; Grymonprez B; Briers Y; Drulis-Kawa Z; Lavigne R
    Appl Microbiol Biotechnol; 2013 May; 97(10):4369-75. PubMed ID: 22832988
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Abdelrahman F; Gangakhedkar R; Nair G; El-Didamony G; Askora A; Jain V; El-Shibiny A
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatic analyses of a potential Salmonella-virus-FelixO1 biocontrol phage BPS15S6 and the characterisation and anti-Enterobacteriaceae-pathogen activity of its endolysin LyS15S6.
    Han H; Li X; Zhang T; Wang X; Zou J; Zhang C; Tang H; Zou Y; Cheng B; Wang R
    Antonie Van Leeuwenhoek; 2019 Nov; 112(11):1577-1592. PubMed ID: 31147967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity.
    Yuan Y; Li X; Wang L; Li G; Cong C; Li R; Cui H; Murtaza B; Xu Y
    Microb Biotechnol; 2021 Mar; 14(2):403-418. PubMed ID: 32519416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).
    Huang G; Shen X; Gong Y; Dong Z; Zhao X; Shen W; Wang J; Hu F; Peng Y
    BMC Infect Dis; 2014 Dec; 14():681. PubMed ID: 25495514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.